alexa Medication Use During Pregnancy In Omani Women
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

2nd International Summit on Clinical Pharmacy
December 02-03, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

Intisar M Al-Riyami, Intisar Q Al-Busaidy and Ibrahim S Al-Zakwani
Posters: Clinic Pharmacol Biopharm
DOI: 10.4172/2167-065X.S1.007
The aim of this study was to evaluate medication use pattern in a university tertiary hospital in the Sultanate of Oman. The study was conducted at the Sultan Qaboos University Hospital (SQUH) and the SQUH Family and Community Medicine clinic (FAMCO), from 7th to 25th June 2008. The medication use pattern was evaluated in women attending FAMCO and the standard antenatal clinics. Women were interviewed in different gestational ages using a structured questionnaire. The Electronic Patient Record was reviewed to acquire additional information on medication use. Medications were classified according to the US FDA risk classification. Main outcome measure medication used including prescribed medications, OTC medications, or herbals during the current pregnancy and 3 months prior to conception. The study included a total of 139 pregnant mothers with an overall mean age of 28?5 years ranging from 19 to 45 years. There was a slight overall reduction in the medication use including prescribed medications. However, there was a significant increase in utilization of vitamins and supplements (84?95% vs. 12% in the 3-months prior, P<0.001) as well as herbal preparations (16?19% vs. 7% in the 3-months prior, P=0.011) throughout pregnancy (P<0.010). The use of category A medications increased in all trimester (43?52% vs. 13% in the 3 months prior, P<0.010) while a reduction in the use of category C (for first and third trimester, P<0.050) and D medications was seen. A reduction in the use of teratogenic drugs in all trimesters (P<0.010) was also observed. It can be concluded that prescribing of vitamins and minerals was optimal. However, the common use of herbal supplements observed warrants special attention due to their unknown risks.
Intisar M Al-Riyami is a Senior Clinical Pharmacist working in Sultan Qaboos University Hospital with a five years experience in the field of hematology and Bone Marrow Transplant. She obtained her BSc in Pharmacy in 2007 from Oman Medical College, Oman, which is affiliated with West Virginia University, USA. She has received training in ?The Hospital for Sick Children?, Toronto, Canada, and King?s College London (UK) (pediatric pharmaceutical care course). Her professional interest includes: Pediatrics, safety in pregnancy, and oncology/hematology. She is also interested in clinical research and currently involved in a clinical research in the area of hematology. She is involved in training junior clinical pharmacist and pharmacy students.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version